Surmodics (SRDX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SRDX Stock Forecast

Surmodics stock forecast is as follows: an average price target of $39.50 (represents a -0.63% downside from SRDX’s last price of $39.75) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

SRDX Price Target

The average price target for Surmodics (SRDX) is $39.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $43.00 to $36.00. This represents a potential -0.63% downside from SRDX's last price of $39.75.

SRDX Analyst Ratings

Buy

According to 2 Wall Street analysts, Surmodics's rating consensus is 'Buy'. The analyst rating breakdown for SRDX stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Surmodics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 29, 2024	Brooks O'Neil	Lake Street	$43.00	$42.07	2.21%	8.18%
Jun 13, 2023	Downgrades Stock	Needham	$36.00	$26.34	36.65%	-9.43%
Apr 28, 2022		Needham	$46.00	$40.05	14.86%	15.72%

The latest Surmodics stock forecast, released on May 29, 2024 by Brooks O'Neil from Lake Street, set a price target of $43.00, which represents a 2.21% increase from the stock price at the time of the forecast ($42.07), and a 8.18% increase from SRDX last price ($39.75).

Surmodics Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$43.00
Last Closing Price	$39.75	$39.75	$39.75
Upside/Downside	-100.00%	-100.00%	8.18%

In the current month, the average price target of Surmodics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Surmodics's last price of $39.75. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
May 30, 2024	Needham	Underperform	Underperform	Hold
May 30, 2024	Sidoti & Co.	Buy	Buy	Hold
May 29, 2024	Lake Street		Hold	Downgrade
Feb 13, 2023	Needham	Buy	Hold	Downgrade
Apr 28, 2022	Needham	Buy	Buy	Hold

Surmodics's last stock rating was published by Needham on May 30, 2024. The company gave SRDX a "Underperform" rating, the same as its previous rate.

Surmodics Financial Forecast

Surmodics Revenue Forecast

	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	$30.55M	$27.97M	$52.48M	$27.20M	$24.93M	$25.99M	$24.85M	$26.11M	$23.00M	$23.97M	$23.87M	$34.99M	$22.30M	$22.54M	$26.88M	$22.82M	$22.62M	$30.82M	$24.34M
Avg Forecast	$39.12M	$35.72M	$37.55M	$36.38M	$37.41M	$34.59M	$35.26M	$33.37M	$30.40M	$29.95M	$28.84M	$29.64M	$26.27M	$26.18M	$25.86M	$24.23M	$24.09M	$25.19M	$23.97M	$23.71M	$23.06M	$23.31M	$32.96M	$22.55M	$20.77M	$23.75M	$20.84M	$22.08M	$28.36M	$22.29M
High Forecast	$39.63M	$36.19M	$38.04M	$36.86M	$37.90M	$35.05M	$35.44M	$33.56M	$30.45M	$29.95M	$28.84M	$29.65M	$26.50M	$26.52M	$26.20M	$24.54M	$24.09M	$25.19M	$23.97M	$23.71M	$23.06M	$23.31M	$32.96M	$22.55M	$20.77M	$23.75M	$20.84M	$22.08M	$28.36M	$22.29M
Low Forecast	$38.73M	$35.37M	$37.17M	$36.02M	$37.04M	$34.25M	$35.07M	$33.18M	$30.34M	$29.95M	$28.84M	$29.62M	$25.99M	$25.92M	$25.61M	$23.98M	$24.09M	$25.19M	$23.97M	$23.71M	$23.06M	$23.31M	$32.96M	$22.55M	$20.77M	$23.75M	$20.84M	$22.08M	$28.36M	$22.29M
# Analysts	1	1	1	1	1	1	2	2	1	1	1	2	4	2	2	1	1	1	1	2	2	2	2	2	10	10	10	9	9	9
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.03%	1.06%	2.00%	1.05%	1.03%	1.08%	0.99%	1.09%	0.97%	1.04%	1.02%	1.06%	0.99%	1.09%	1.13%	1.09%	1.02%	1.09%	1.09%

Surmodics's average Quarter revenue forecast for Mar 24 based on 1 analysts is $28.84M, with a low forecast of $28.84M, and a high forecast of $28.84M. SRDX's average Quarter revenue forecast represents a -5.59% decrease compared to the company's last Quarter revenue of $30.55M (Dec 23).

Surmodics EBITDA Forecast

	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
# Analysts	1	1	1	1	1	1	2	2	1	1	1	2	4	2	2	1	1	1	1	2	2	2	2	2	10	10	10	9	9	9
EBITDA	-	-	-	-	-	-	-	-	-	-	-	$-322.00K	$-293.00K	$21.41M	$-1.93M	$-5.11M	$-5.65M	$-4.93M	$-2.58M	$270.00K	$1.98M	$-608.00K	$11.49M	$1.75M	$-171.00K	$3.03M	$1.34M	$1.74M	$6.01M	$3.13M
Avg Forecast	$1.41M	$1.28M	$1.35M	$1.31M	$1.35M	$1.24M	$1.27M	$1.20M	$1.09M	$1.08M	$-4.18M	$1.07M	$944.79K	$941.42K	$-3.80M	$485.88K	$983.23K	$1.03M	$-3.45M	$967.46K	$941.23K	$951.36K	$11.67M	$920.23K	$847.49K	$969.31K	$2.85M	$901.06K	$1.16M	$909.69K
High Forecast	$1.43M	$1.30M	$1.37M	$1.33M	$1.36M	$1.26M	$1.27M	$1.21M	$1.09M	$1.08M	$-3.34M	$1.07M	$953.06K	$953.76K	$-3.04M	$583.06K	$983.23K	$1.03M	$-2.76M	$967.46K	$941.23K	$951.36K	$14.01M	$920.23K	$847.49K	$969.31K	$3.42M	$901.06K	$1.16M	$909.69K
Low Forecast	$1.39M	$1.27M	$1.34M	$1.30M	$1.33M	$1.23M	$1.26M	$1.19M	$1.09M	$1.08M	$-5.02M	$1.07M	$934.72K	$931.98K	$-4.56M	$388.70K	$983.23K	$1.03M	$-4.14M	$967.46K	$941.23K	$951.36K	$9.34M	$920.23K	$847.49K	$969.31K	$2.28M	$901.06K	$1.16M	$909.69K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-0.30%	-0.31%	22.74%	0.51%	-10.51%	-5.74%	-4.80%	0.75%	0.28%	2.10%	-0.64%	0.98%	1.90%	-0.20%	3.13%	0.47%	1.93%	5.19%	3.44%

4 analysts predict SRDX's average Quarter EBITDA for Sep 23 to be $944.79K, with a high of $953.06K and a low of $934.72K. This is -95.59% lower than Surmodics's previous annual EBITDA (Jun 23) of $21.41M.

Surmodics Net Income Forecast

	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
# Analysts	1	1	1	1	1	1	2	2	1	1	1	2	4	2	2	1	1	1	1	2	2	2	2	2	10	10	10	9	9	9
Net Income	-	-	-	-	-	-	-	-	-	-	-	$-786.00K	$6.69M	$33.95M	$-7.73M	$-7.84M	$-14.73M	$-5.65M	$-4.08M	$-4.22M	$-289.00K	$-3.29M	$8.09M	$62.00	$-2.95M	$2.46M	$1.46M	$148.00K	$3.55M	$1.47M
Avg Forecast	$-1.28M	$-1.14M	$-1.14M	$-1.14M	$-47.29K	$-472.96K	$-1.23M	$-1.66M	$-4.16M	$-4.79M	$-6.68M	$-4.61M	$2.23M	$-6.53M	$-6.08M	$-5.06M	$-6.73M	$-5.70M	$-5.52M	$-4.36M	$-3.72M	$-2.59M	$8.22M	$-921.05K	$-1.66M	$1.95M	$3.11M	$-1.10M	$4.71M	$495.95K
High Forecast	$-1.26M	$-1.12M	$-1.12M	$-1.12M	$-46.67K	$-466.80K	$307.43K	$-1.24M	$-4.11M	$-4.73M	$-5.35M	$-4.55M	$2.61M	$-6.44M	$-4.86M	$-4.05M	$-6.73M	$-5.70M	$-4.42M	$-4.36M	$-3.72M	$-2.59M	$9.86M	$-921.05K	$-1.66M	$1.95M	$3.73M	$-1.10M	$4.71M	$495.95K
Low Forecast	$-1.30M	$-1.15M	$-1.15M	$-1.15M	$-48.10K	$-481.02K	$-2.46M	$-1.86M	$-4.23M	$-4.87M	$-8.02M	$-4.69M	$1.99M	$-6.64M	$-7.29M	$-6.07M	$-6.73M	$-5.70M	$-6.63M	$-4.36M	$-3.72M	$-2.59M	$6.57M	$-921.05K	$-1.66M	$1.95M	$2.49M	$-1.10M	$4.71M	$495.95K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.17%	3.00%	-5.20%	1.27%	1.55%	2.19%	0.99%	0.74%	0.97%	0.08%	1.27%	0.98%	-0.00%	1.77%	1.26%	0.47%	-0.13%	0.75%	2.96%

Surmodics's average Quarter net income forecast for Dec 23 is $-4.61M, with a range of $-4.69M to $-4.55M. SRDX's average Quarter net income forecast represents a -168.89% decrease compared to the company's last Quarter net income of $6.69M (Sep 23).

Surmodics SG&A Forecast

	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
# Analysts	1	1	1	1	1	1	2	2	1	1	1	2	4	2	2	1	1	1	1	2	2	2	2	2	10	10	10	9	9	9
SG&A	-	-	-	-	-	-	-	-	-	-	-	$12.54M	$12.81M	$12.87M	$12.97M	$13.24M	$13.78M	$12.85M	$11.11M	$9.19M	$7.86M	$7.88M	$7.91M	$7.02M	$7.30M	$7.42M	$6.73M	$6.94M	$7.19M	$5.94M
Avg Forecast	$14.89M	$13.60M	$14.29M	$13.85M	$14.24M	$13.17M	$13.42M	$12.70M	$11.57M	$11.40M	$18.19M	$11.28M	$10.00M	$9.96M	$16.54M	$16.54M	$8.15M	$8.52M	$15.04M	$8.02M	$7.80M	$7.89M	$8.03M	$7.63M	$7.03M	$8.03M	$14.32M	$7.47M	$9.59M	$7.54M
High Forecast	$15.08M	$13.77M	$14.48M	$14.03M	$14.43M	$13.34M	$13.49M	$12.77M	$11.59M	$11.40M	$21.83M	$11.29M	$10.09M	$10.09M	$19.85M	$19.85M	$8.15M	$8.52M	$18.04M	$8.02M	$7.80M	$7.89M	$9.64M	$7.63M	$7.03M	$8.03M	$17.19M	$7.47M	$9.59M	$7.54M
Low Forecast	$14.74M	$13.46M	$14.15M	$13.71M	$14.10M	$13.03M	$13.35M	$12.63M	$11.55M	$11.40M	$14.55M	$11.27M	$9.89M	$9.86M	$13.23M	$13.23M	$8.15M	$8.52M	$12.03M	$8.02M	$7.80M	$7.89M	$6.43M	$7.63M	$7.03M	$8.03M	$11.46M	$7.47M	$9.59M	$7.54M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.11%	1.28%	1.29%	0.78%	0.80%	1.69%	1.51%	0.74%	1.15%	1.01%	1.00%	0.98%	0.92%	1.04%	0.92%	0.47%	0.93%	0.75%	0.79%

Surmodics's average Quarter SG&A projection for Mar 24 is $18.19M, based on 1 Wall Street analysts, with a range of $14.55M to $21.83M. The forecast indicates a 45.11% rise compared to SRDX last annual SG&A of $12.54M (Dec 23).

Surmodics EPS Forecast

	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
# Analysts	1	1	1	1	1	1	2	2	1	1	1	2	4	2	2	1	1	1	1	2	2	2	2	2	10	10	10	9	9	9
EPS	-	-	-	-	-	-	-	-	-	-	-	$-0.06	$0.48	$2.42	$-0.55	$-0.56	$-1.06	$-0.41	$-0.29	$-0.30	$-0.02	$-0.24	$0.59	-	$-0.22	$0.18	$0.11	$0.01	$0.27	$0.11
Avg Forecast	$-0.09	$-0.08	$-0.08	$-0.08	$-0.00	$-0.03	$-0.09	$-0.12	$-0.29	$-0.34	$-0.35	$-0.33	$0.16	$-0.46	$-0.55	$-0.63	$-0.47	$-0.40	$-0.36	$-0.31	$-0.26	$-0.18	$0.56	$-0.07	$-0.12	$0.14	$-0.14	$-0.08	$0.33	$0.04
High Forecast	$-0.09	$-0.08	$-0.08	$-0.08	$-0.00	$-0.03	$0.02	$-0.09	$-0.29	$-0.33	$-0.35	$-0.32	$0.18	$-0.45	$-0.54	$-0.62	$-0.47	$-0.40	$-0.36	$-0.31	$-0.26	$-0.18	$0.56	$-0.07	$-0.12	$0.14	$-0.14	$-0.08	$0.33	$0.04
Low Forecast	$-0.09	$-0.08	$-0.08	$-0.08	$-0.00	$-0.03	$-0.17	$-0.13	$-0.30	$-0.34	$-0.36	$-0.33	$0.14	$-0.47	$-0.56	$-0.64	$-0.47	$-0.40	$-0.36	$-0.31	$-0.26	$-0.18	$0.56	$-0.07	$-0.12	$0.14	$-0.14	$-0.08	$0.33	$0.04
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.17%	3.05%	-5.26%	1.00%	0.89%	2.23%	1.02%	0.79%	0.98%	0.08%	1.32%	1.06%	-0.00%	1.87%	1.31%	-0.79%	-0.13%	0.81%	3.14%

According to 2 Wall Street analysts, Surmodics's projected average Quarter EPS for Dec 23 is $-0.33, with a low estimate of $-0.33 and a high estimate of $-0.32. This represents a -167.71% decrease compared to SRDX previous annual EPS of $0.48 (Sep 23).

Surmodics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
APYX	Apyx Medical	$1.64	$8.50	418.29%	Buy
INGN	Inogen	$9.12	$26.00	185.09%	Buy
LUNG	Pulmonx	$6.13	$13.00	112.07%	Buy
SGHT	Sight Sciences	$3.62	$7.50	107.18%	Hold
KIDS	OrthoPediatrics	$22.46	$39.50	75.87%	Buy
LIVN	LivaNova	$49.94	$68.25	36.66%	Buy
CNMD	CONMED	$71.23	$97.00	36.18%	Buy
OFIX	Orthofix Medical	$17.93	$24.00	33.85%
SIBN	SI-BONE	$13.84	$18.50	33.67%	Buy
NPCE	NeuroPace	$11.52	$15.00	30.21%	Buy
ITGR	Integer	$136.68	$153.50	12.31%	Buy
FNA	Paragon 28	$10.36	$11.50	11.00%	Buy
SRDX	Surmodics	$39.96	$39.50	-1.15%	Buy

SRDX Forecast FAQ

Is Surmodics a good buy?

Yes, according to 2 Wall Street analysts, Surmodics (SRDX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of SRDX's total ratings.

What is SRDX's price target?

Surmodics (SRDX) average price target is $39.5 with a range of $36 to $43, implying a -0.63% from its last price of $39.75. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Surmodics stock go up soon?

According to Wall Street analysts' prediction for SRDX stock, the company can go down by -0.63% (from the last price of $39.75 to the average price target of $39.5), up by 8.18% based on the highest stock price target, and down by -9.43% based on the lowest stock price target.

Can Surmodics stock reach $60?

SRDX's average twelve months analyst stock price target of $39.5 does not support the claim that Surmodics can reach $60 in the near future.

What are Surmodics's analysts' financial forecasts?

Surmodics's analysts financial forecasts for the fiscal year (Sep 2025) are as follows: average revenue is $140.63M (high $141.95M, low $139.53M), average EBITDA is $5.06M (high $5.1M, low $5.02M), average net income is $-3.405M (high $-1.448M, low $-4.851M), average SG&A $53.52M (high $54.02M, low $53.1M), and average EPS is $-0.24 (high $-0.102, low $-0.342). SRDX's analysts financial forecasts for the fiscal year (Sep 2026) are as follows: average revenue is $148.78M (high $150.73M, low $147.29M), average EBITDA is $5.35M (high $5.42M, low $5.3M), average net income is $-4.682M (high $-4.621M, low $-4.762M), average SG&A $56.62M (high $57.37M, low $56.06M), and average EPS is $-0.33 (high $-0.326, low $-0.336).

Did the SRDX's actual financial results beat the analysts' financial forecasts?

Based on Surmodics's last annual report (Sep 2023), the company's revenue was $132.58M, beating the average analysts forecast of $102.54M by 29.30%. Apple's EBITDA was $14.58M, missing the average prediction of $-1.427M by -1121.32%. The company's net income was $-1.536M, missing the average estimation of $-15.429M by -90.04%. Apple's SG&A was $51.88M, missing the average forecast of $53.04M by -2.19%. Lastly, the company's EPS was $-0.11, missing the average prediction of $-1.479 by -92.56%. In terms of the last quarterly report (Dec 2023), Surmodics's revenue was $30.55M, beating the average analysts' forecast of $29.64M by 3.06%. The company's EBITDA was $-322K, missing the average prediction of $1.07M by -130.21%. Surmodics's net income was $-786K, missing the average estimation of $-4.611M by -82.96%. The company's SG&A was $12.54M, beating the average forecast of $11.28M by 11.12%. Lastly, the company's EPS was $-0.0557, missing the average prediction of $-0.325 by -82.86%